These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 4946616)

  • 41. The use of stable isotopes in pharmacological research.
    Baillie TA
    Pharmacol Rev; 1981 Jun; 33(2):81-132. PubMed ID: 7029573
    [No Abstract]   [Full Text] [Related]  

  • 42. Micelle formation and its significance in interpretation of NMR spectra of phenothiazine derivatives.
    Ravin LJ; Warren RJ
    J Pharm Sci; 1971 Feb; 60(2):329. PubMed ID: 5572472
    [No Abstract]   [Full Text] [Related]  

  • 43. [Use of chromato-mass-spectrometry in pharmacokinetic research (review of the literature)].
    Kozlev ST; Rudzit EA
    Farmakol Toksikol; 1976; 39(6):750-5. PubMed ID: 1024846
    [No Abstract]   [Full Text] [Related]  

  • 44. [An identification system for drugs by means of oscillopolarography].
    Dusinský G; Faith L
    Pharmazie; 1967 Sep; 22(9):475-82. PubMed ID: 5599142
    [No Abstract]   [Full Text] [Related]  

  • 45. [EPR-spectra of cation radicals of promazine and chlorpromazine].
    Fenner H; Möckel H
    Tetrahedron Lett; 1969 Jul; (33):2815-8. PubMed ID: 4309632
    [No Abstract]   [Full Text] [Related]  

  • 46. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Automated optimization of mass spectrometric parameters in 'Tune' mode for impure analytes in dirty samples using gradient high-performance liquid chromatography.
    Rogatsky E; Stein D
    Rapid Commun Mass Spectrom; 2005; 19(24):3759-60. PubMed ID: 16308844
    [No Abstract]   [Full Text] [Related]  

  • 48. Finding key impurities in different manufacturing routes of a drug substance using liquid chromatography/mass spectrometry followed by principal components analysis.
    Carrier D; Eckers C; Arnoult T; Thurston T; Major H
    Rapid Commun Mass Spectrom; 2007; 21(23):3946-8. PubMed ID: 17975854
    [No Abstract]   [Full Text] [Related]  

  • 49. [Critical analysis of different methods used for toxicology screening in emergency laboratory].
    Pechard A; Besson AS; Mialon A; Berny C; Manchon M
    Ann Biol Clin (Paris); 1999; 57(5):525-37. PubMed ID: 10518054
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of cysteinylation of pharmaceutical-grade human serum albumin by electrospray ionization mass spectrometry and low-energy collision-induced dissociation tandem mass spectrometry.
    Kleinova M; Belgacem O; Pock K; Rizzi A; Buchacher A; Allmaier G
    Rapid Commun Mass Spectrom; 2005; 19(20):2965-73. PubMed ID: 16178042
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Solubility of drugs as criterion for drug liberation from fat-like, galenic bases (Cetylium phthalicum, lasupol G) with reference to viscosity increasing adjuvant substances].
    Voigt R; Falk G
    Pharmazie; 1968 Dec; 23(12):709-14. PubMed ID: 4304717
    [No Abstract]   [Full Text] [Related]  

  • 52. Strategies for characterization of drug metabolites using liquid chromatography-tandem mass spectrometry in conjunction with chemical derivatization and on-line H/D exchange approaches.
    Liu DQ; Hop CE
    J Pharm Biomed Anal; 2005 Feb; 37(1):1-18. PubMed ID: 15664738
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Use of stable isotopes in analytical methods].
    Julien-Larose C
    Therapie; 1987 Sep; 42(5):429-33. PubMed ID: 3441885
    [No Abstract]   [Full Text] [Related]  

  • 54. A reversed-phase thin-layer chromotographic method for the determination of relative partition coefficients of very lipophilic compounds.
    Hulshoff A; Perrin JH
    J Chromatogr; 1976 May; 120(1):65-80. PubMed ID: 5460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Use of gas chromatography and mass spectrometry in forensic chemistry for the demonstration of drugs and their metabolites].
    Chundela B; Slechtová R
    Beitr Gerichtl Med; 1974; 32():206-14. PubMed ID: 4468785
    [No Abstract]   [Full Text] [Related]  

  • 56. Analytical controls in drug metabolic studies. A commentary.
    Cone EJ; Gorodetzky CW
    Drug Metab Dispos; 1975; 3(5):417-8. PubMed ID: 241623
    [No Abstract]   [Full Text] [Related]  

  • 57. Analysis of promazine and chlorpromazine in pharmaceutical preparations.
    MILNE JB; CHATTEN LG
    J Pharm Pharmacol; 1957 Oct; 9(10):686-90. PubMed ID: 13476385
    [No Abstract]   [Full Text] [Related]  

  • 58. [Mass spectrometry assay: technics and development].
    Mignot A; Fourtillan JB
    Therapie; 1987 Sep; 42(5):423-7. PubMed ID: 3441884
    [No Abstract]   [Full Text] [Related]  

  • 59. [Mass spectrophotometric analysis of natural and medicinal materials].
    Moll F
    Mitt Dtsch Pharm Ges Pharm Ges DDR; 1969 Jun; 39(6):125-41. PubMed ID: 4919587
    [No Abstract]   [Full Text] [Related]  

  • 60. Identification of thiamphenicol excretion products in rat urine using gas-chromatography--mass-spectrometry.
    Cattabeni F; Gazzaniga A
    Postgrad Med J; 1974 Oct; 50 Suppl 5():23-7. PubMed ID: 4470812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.